These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 16798114

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Distinct pattern of lung gene expression in the Cftr-KO mice developing spontaneous lung disease compared with their littermate controls.
    Guilbault C, Novak JP, Martin P, Boghdady ML, Saeed Z, Guiot MC, Hudson TJ, Radzioch D.
    Physiol Genomics; 2006 Apr 13; 25(2):179-93. PubMed ID: 16418321
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Osteopenia in Cftr-deltaF508 mice.
    Paradis J, Wilke M, Haston CK.
    J Cyst Fibros; 2010 Jul 13; 9(4):239-45. PubMed ID: 20570219
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cystic fibrosis transmembrane conductance regulator (CFTR) dependent cytoskeletal tension during lung organogenesis.
    Cohen JC, Larson JE.
    Dev Dyn; 2006 Oct 13; 235(10):2736-48. PubMed ID: 16906518
    [Abstract] [Full Text] [Related]

  • 28. Some like it hot: curcumin and CFTR.
    Davis PB, Drumm ML.
    Trends Mol Med; 2004 Oct 13; 10(10):473-5. PubMed ID: 15464445
    [Abstract] [Full Text] [Related]

  • 29. S-nitrosylating agents: a novel class of compounds that increase cystic fibrosis transmembrane conductance regulator expression and maturation in epithelial cells.
    Zaman K, Carraro S, Doherty J, Henderson EM, Lendermon E, Liu L, Verghese G, Zigler M, Ross M, Park E, Palmer LA, Doctor A, Stamler JS, Gaston B.
    Mol Pharmacol; 2006 Oct 13; 70(4):1435-42. PubMed ID: 16857740
    [Abstract] [Full Text] [Related]

  • 30. Stimulation of salivary secretion in vivo by CFTR potentiators in Cftr+/+ and Cftr-/- mice.
    Noël S, Strale PO, Dannhoffer L, Wilke M, DeJonge H, Rogier C, Mettey Y, Becq F.
    J Cyst Fibros; 2008 Mar 13; 7(2):128-33. PubMed ID: 17766192
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Involvement of cystic fibrosis transmembrane conductance regulator in infection-induced edema.
    Ajonuma LC, He Q, Sheung Chan PK, Yu Ng EH, Fok KL, Yan Wong CH, Tsang LL, Ho LS, Lau MC, Huang HY, Yang DZ, Rowlands DK, Tang XX, Zhang XH, Chung YW, Chan HC.
    Cell Biol Int; 2008 Jul 13; 32(7):801-6. PubMed ID: 18462959
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Defective formation of PKA/CnA-dependent annexin 2-S100A10/CFTR complex in DeltaF508 cystic fibrosis cells.
    Borthwick LA, Riemen C, Goddard C, Colledge WH, Mehta A, Gerke V, Muimo R.
    Cell Signal; 2008 Jun 13; 20(6):1073-83. PubMed ID: 18346874
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Severe osteopenia in CFTR-null mice.
    Dif F, Marty C, Baudoin C, de Vernejoul MC, Levi G.
    Bone; 2004 Sep 13; 35(3):595-603. PubMed ID: 15336594
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.